Risk of Ovarian Cancer Relapse Score-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Ovarian Cancer Relapse Score

Published:2015-03 Issue:3 Volume:25 Page:416-422
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Rizzuto Ivana,Stavraka Chara,Chatterjee Jayanta,Borley Jane,Hopkins Thomas Glass,Gabra Hani,Ghaem-Maghami Sadaf,Huson Les,Blagden Sarah P.

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference26 articles.

1. Cancer statistics, 2013

2. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

4. Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

5. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic analyses reveal that Pueraria montana var. lobata (Willd.) is effective in inhibiting ovarian cancer progression;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-29

2. Survival Outcomes Following Interval Versus Primary Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Retrospective Cohort Study in Lagos, Southwest Nigeria;Journal of Gynecologic Surgery;2024-05-08

3. Clinicopathological Nomogram for Predicting Platinum-Resistant/Refractory Epithelial Ovarian Cancer;Indian Journal of Gynecologic Oncology;2024-04-13

4. Survival outcomes following interval versus primary debulking surgery in advanced epithelial ovarian cancer: A retrospective cohort study in Lagos, Southwest Nigeria;2024-01-05

5. Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer;Future Science OA;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3